Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/8944
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKocketkova, M.-
dc.contributor.authorIversen, P.-
dc.contributor.authorLopez, A.-
dc.contributor.authorShannon, M.-
dc.date.issued1997-
dc.identifier.citationJournal of Clinical Investigation, 1997; 99(12):3000-3008-
dc.identifier.issn0021-9738-
dc.identifier.issn1558-8238-
dc.identifier.urihttp://hdl.handle.net/2440/8944-
dc.description.abstractJuvenile myelomonocytic leukemia (JMML) is a severe childhood malignancy. The autocrine production of GMCSF is believed to be responsible for the spontaneous proliferation of JMML cells. A nuclear factor-kappaB (NF-kappaB)/Rel binding site within the GM-CSF gene promoter, termed the kappaB element, plays an important role in controlling transcription from the GM-CSF gene. We investigated the effect of an oligonucleotide GM3, directed to form a DNA triple helix across this kappaB element, on growth and GM-CSF production by JMML cells. Treatment of these cells, either unstimulated or induced by TNFalpha, with GM3 led to a significant and specific inhibition of both GM-CSF production and spontaneous colony formation. This constitutes the first report linking specific triplex-mediated inhibition of gene transcription with a functional outcome; i.e., cell growth. We observed the constitutive presence of NF-kappaB/Rel proteins in the nucleus of JMML cells. The constitutive and TNFalpha-induced NF-kappaB/Rel complexes were identical and were composed mainly of p50 and c-Rel proteins. Treatment of the cells with a neutralizing anti-TNFalpha monoclonal antibody completely abrogated constitutive nuclear expression of NF-kappaB/Rel proteins. These results indicate that the aberrant, constitutive GM-CSF gene activation in JMML is maintained by TNFalpha-mediated activation of NF-kappaB/Rel proteins. Our findings identify the molecular basis for the autocrine TNFalpha activation of the GM-CSF gene in JMML and suggest potential novel and specific approaches for the treatment of this aggressive childhood leukemia.-
dc.language.isoen-
dc.publisherAmerican Society for Clinical Investigation-
dc.source.urihttp://dx.doi.org/10.1172/jci119495-
dc.subjectCell Nucleus-
dc.subjectHumans-
dc.subjectLeukemia, Myelomonocytic, Chronic-
dc.subjectTumor Necrosis Factor-alpha-
dc.subjectNF-kappa B-
dc.subjectGranulocyte-Macrophage Colony-Stimulating Factor-
dc.subjectDNA-
dc.subjectOligodeoxyribonucleotides-
dc.subjectCell Division-
dc.subjectGene Expression-
dc.subjectBinding Sites-
dc.subjectNucleic Acid Conformation-
dc.subjectChild, Preschool-
dc.subjectInfant-
dc.subjectSp1 Transcription Factor-
dc.subjectPromoter Regions, Genetic-
dc.titleDeoxyribo-nucleic acid triplex formation inhibits granulocyte-macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.-
dc.typeJournal article-
dc.identifier.doi10.1172/JCI119495-
pubs.publication-statusPublished-
dc.identifier.orcidLopez, A. [0000-0001-7430-0135]-
Appears in Collections:Aurora harvest
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.